The cellular immunotherapy space has exploded over the past few years and we are now entering the cell therapy revolution. The progress has been unprecedented however, there are still a number of challenges that need to be addressed.
CAR-TCR Summit Europe, returning due to popular demand, allows you to join the top minds from large pharma, biotech and academia who are striving to harmonise the European regulatory process, streamline manufacturing and optimise CAR-T targets and constructs for solid tumours.
Covering the full pharmaceutical value chain from discovery through to commercialisation, this meeting will equip you with the lessons learned to overcome the glass ceiling in manufacturing, safety management and patient accessibility.
In order for you to gain the insight and value you need to progress the feld learn from experts actively involved in making decisions that matter.
The 2020 meeting will span across 4 full days including 9 discussion-based workshops, 2 fullsummit days with 3 focused tracks of content, followed by two focus day sessions brought to youby the with clinicians running trials at the NHS.
This 3 tracked agenda provides a platform for the European community to come together, whilstensuring you have meaningful conversations with those facing the same challenges as you.
I look forward to welcoming you to discover the tools needed to engineer a cancer free world.